Alessandra Ravaioli
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cancer Research top 10%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Fabio FalciniLauro BucchiM. MarangoloLucio CrinòSandro BarniGiorgio CrucianiD. AmadoriRoberto Bianco
- Topics
- Breast Cancer Treatment Studies (21 papers)Cancer Treatment and Pharmacology (20 papers)Global Cancer Incidence and Screening (19 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Alessandra Ravaioli
103 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 91
- Oncology 913
- Pulmonary and Respiratory Medicine 533
- Molecular Biology 210
- Cancer Research 209
- Pathology and Forensic Medicine 170
Countries citing papers authored by Alessandra Ravaioli
This map shows the geographic impact of Alessandra Ravaioli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Ravaioli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Ravaioli more than expected).
Fields of papers citing papers by Alessandra Ravaioli
This network shows the impact of papers produced by Alessandra Ravaioli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Ravaioli. The network helps show where Alessandra Ravaioli may publish in the future.
Co-authorship network of co-authors of Alessandra Ravaioli
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Ravaioli. A scholar is included among the top collaborators of Alessandra Ravaioli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Ravaioli. Alessandra Ravaioli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 2 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 7 | |
| 10 | 18 | |
| 11 | 67 | |
| 12 | 17 | |
| 13 | 12 | |
| 14 | Randomised trial comparing doxorubicin, paclitaxel (AT), versus paclitaxel (T), as second line therapy for advanced ovarian cancer (AOC) patients in early progression after platinum-based chemotherapy. | 5 |
| 15 | 9 | |
| 16 | 13 | |
| 17 | Prospective use of tumor proliferative activity for adjuvant therapy in node-negative breast cancer patients | 1 |
| 18 | 2 | |
| 19 | A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer. | 35 |
| 20 | 10 |
About Alessandra Ravaioli
Alessandra Ravaioli is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 107 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (21 papers), Cancer Treatment and Pharmacology (20 papers) and Global Cancer Incidence and Screening (19 papers). The work is most often cited by research in Oncology (913 citations), Pulmonary and Respiratory Medicine (533 citations) and Cancer Research (209 citations). Alessandra Ravaioli has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Fabio Falcini, Lauro Bucchi, M. Marangolo, Lucio Crinò, Sandro Barni, Giorgio Cruciani, D. Amadori, Roberto Bianco, Filippo de Marinis and Cesare Gridelli. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.